Skip to main content

Peer Review reports

From: Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50%

Original Submission
20 Apr 2023 Submitted Original manuscript
4 May 2023 Author responded Author comments - Junxian Yu
5 Jun 2023 Reviewed Reviewer Report
14 Jun 2023 Reviewed Reviewer Report
16 Jun 2023 Author responded Author comments - Junxian Yu
Resubmission - Version 2
4 May 2023 Submitted Manuscript version 2
30 Jun 2023 Author responded Author comments - Junxian Yu
Resubmission - Version 3
30 Jun 2023 Submitted Manuscript version 3
5 Jul 2023 Author responded Author comments - Junxian Yu
Resubmission - Version 4
5 Jul 2023 Submitted Manuscript version 4
6 Jul 2023 Author responded Author comments - Junxian Yu
Resubmission - Version 5
6 Jul 2023 Submitted Manuscript version 5
9 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
10 Aug 2023 Editorially accepted
23 Aug 2023 Article published 10.1186/s12885-023-11285-4

You can find further information about peer review here.

Back to article page